Brief: LianBio Believes Transaction With Pfizer Will Extend Its Cash Runway
Dec 19 (Reuters) - LianBio LIAN.O :
* LIANBIO- BELIEVES TRANSACTION WITH PFIZER WILL EXTEND
LIANBIO’S
CASH RUNWAY THROUGH THE END OF 2024
* LIANBIO-PFIZER’S PAYMENT OBLIGATIONS TO CO UNDER
COMMERCIAL
AGREEMENT STARTS FROM FIRST COMMERCIAL SALE OF SISUNATOVIR IN
TERRITORY UNTIL OCT 2035 END
Further company coverage: LIAN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LianBio
See all newsChina's Zeekr prices US IPO at top of range to raise $441 million (updated)
U.S. STOCKS ON THE MOVE-JetBlue Airways, LPL Financial, Nvidia
U.S. STOCKS ON THE MOVE-Bicycle Therapeutics, Molson Coors, LianBio
LianBio completes strategic review, cuts jobs; shares up
Brief: LianBio Announces Completion Of Strategic Review